The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for November 2008 (PDF).
This issue provides a safety update regarding adverse psychiatric reactions linked to varenicline use. There is also a hot topic discussion regarding the possible increased risk of cancer associated with ezetimibe. Finally, the stop press section reminds clinicians about the withdrawal of rimonabant, recent concerns regarding inhaled anticholinergics and paracetamol in infants.
Action: Clinicians will find this publication to be a useful review of current issues in drug safety.
|« November CKS Update||Statin study finds benefits for healthy »|